Rare diseases
Investigational molecules
Locations
Back to Germany24 clinical trials in Troisdorf, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on IPN10200 for Treating Cervical Dystonia in Adults
GermanyStudy of LY3484356 (imlunestrant) with Tamoxifen Citrate and Goserelin Acetate in Premenopausal Women with ER‑Positive, HER2‑Negative Early Breast Cancer
GermanyNeoadjuvant Sacituzumab Govitecan and Pembrolizumab for Patients with Clinical Stage II-III Triple-Negative Early Breast Cancer
GermanyStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
GermanyA study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
GermanyA study testing zanidatamab combined with chemotherapy before surgery in patients with HER2-positive breast cancer
GermanyA study comparing datopotamab deruxtecan with durvalumab versus datopotamab deruxtecan alone for patients with PDL1-negative metastatic triple-negative breast cancer
GermanyStudy of durvalumab with chemotherapy (paclitaxel, cisplatin, carboplatin, vinorelbine) in patients with stage IIIA/B non-small cell lung cancer that can be removed by surgery
GermanyStudy of accelerated chemoradiotherapy followed by durvalumab treatment in patients with locally advanced non-small-cell lung cancer (NSCLC) using PET imaging guidance
GermanyStudy Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer
GermanyStudy of Capivasertib and Fulvestrant for Patients with High-Risk Lobular Breast Cancer
GermanyStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery
GermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on triple-negative breast cancer and HER2-positive variants, evaluating innovative therapeutic approaches including immunotherapy and targeted treatments.
Multiple trials investigating personalized treatment approaches and novel drug combinations to improve patient outcomes.
Research initiatives examining non-small cell lung cancer treatments, with particular emphasis on combining immunotherapy with conventional treatments.
Innovative approaches including FDG-PET-based therapies and home treatment solutions are being evaluated.
Studies focused on preventing ischemic stroke and managing post-stroke complications using novel therapeutic agents.
Trials evaluating oral FXIa inhibitors and their efficacy in preventing recurrent strokes.
Advanced research in Hodgkin Lymphoma treatment, comparing different therapeutic regimens to optimize patient outcomes.
Focus on developing less toxic treatment options while maintaining therapeutic efficacy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
